Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Lactobacillus plantarum 299v

What does the research say about Lactobacillus plantarum 299v?

6 health outcomes synthesised

Lactobacillus plantarum 299v is a probiotic strain studied across 6 health outcomes, with the strongest evidence supporting improved iron levels (4 studies; moderate evidence strength) and improved irritable bowel syndrome symptoms (4 studies; moderate evidence strength). Effective doses in research typically converge around 1×10^10 CFU per day, with clinical populations such as adults with iron deficiency or IBS showing the most pronounced benefits.

Strongest evidence: The most robust findings are for improved iron levels (4 studies, moderate evidence) and improved IBS symptoms (4 studies, moderate evidence). For iron, 3 of 4 studies reported significant benefits with a moderate effect size, typically at 10^10 CFU/day over 90 days, particularly in iron-deficient adults. For IBS, 3 of 4 studies showed large effects (e.g., 95% improvement vs 15% placebo in one small RCT), though one meta-analysis was neutral.

Mixed or weaker evidence: Outcomes with low evidence strength include improved quality of life (3 of 4 studies beneficial, moderate effect), reduced abdominal pain (3 of 4 beneficial, but mixed effect sizes), improved bowel movement frequency (only 1 of 3 studies beneficial, small effect), and reduced flatulence (2 of 3 beneficial but inconsistent, mixed effects). These areas are characterized by small study sizes and conflicting results between observational studies and RCTs.

Effective dose patterns: The most commonly reported effective dose across outcomes is 1×10^10 CFU/day, observed for iron levels, IBS symptoms, quality of life, and abdominal pain. For flatulence, doses ranged from 1×10^10 to 2×10^10 CFU/day. Some studies did not specify dose, limiting cross-outcome convergence.

Population insights: Benefits are most consistently observed in clinical populations rather than healthy individuals. Iron level improvements were more pronounced in adults with iron deficiency anemia than in healthy pregnant women. IBS patients and those with other clinical conditions (e.g., Hashimoto's thyroiditis, cancer on enteral nutrition) showed benefits across multiple outcomes.

Notable caveats: Most evidence bases are small (3–4 studies per outcome), making conclusions preliminary. Publication bias is a concern across all positive outcomes, as null results are less likely to be published. Some neutral findings come from larger or higher-quality studies, which may temper effect estimates. Two studies for iron did not specify dose, and study durations varied widely (4–12 weeks).

Frequently asked

  • What is Lactobacillus plantarum 299v good for according to research?
    Research suggests Lactobacillus plantarum 299v may support improved iron levels and reduced irritable bowel syndrome (IBS) symptoms, both supported by moderate-strength evidence from 4 studies each. Weaker evidence also points to potential benefits for quality of life, abdominal pain, bowel movement frequency, and flatulence, though these findings are more mixed.
  • What dose of Lactobacillus plantarum 299v is typically used in studies?
    The most common effective dose across studies is 1×10^10 colony-forming units (CFU) per day, used for iron levels, IBS symptoms, quality of life, and abdominal pain. For flatulence, doses ranged from 1×10^10 to 2×10^10 CFU per day, though not all studies specified the dose.
  • Who benefits most from Lactobacillus plantarum 299v?
    Benefit appears strongest in clinical populations: adults with iron deficiency anemia showed more pronounced improvements in iron levels than healthy pregnant women. IBS patients also consistently showed benefits across multiple outcomes, including symptom reduction and quality of life. Evidence in healthy individuals is limited.
  • Are there caveats or limitations in the research on Lactobacillus plantarum 299v?
    Yes, the evidence base is small (3–4 studies per outcome), making conclusions preliminary. Publication bias is a concern, as positive results are more likely to be published. Some neutral findings come from larger or higher-quality studies (e.g., a meta-analysis for IBS, an RCT for flatulence), which may reduce confidence in the overall effect.
  • Does Lactobacillus plantarum 299v help with irritable bowel syndrome symptoms?
    Moderate-strength evidence from 4 studies indicates a beneficial effect: 3 studies reported significant symptom improvement with large effect sizes, though one meta-analysis found neutral results. The recommended dose in these studies was approximately 1×10^10 CFU/day, with effects observed over 4 to 12 weeks.
  • Does Lactobacillus plantarum 299v improve iron levels?
    Moderate-strength evidence from 4 studies shows that 3 reported statistically significant improvements in iron levels, with a moderate effect size. Benefits were more pronounced in adults with iron deficiency anemia than in healthy pregnant women, typically at 10^10 CFU/day over 90 days.

Safety profile

4 studies reporting safety data

Across 4 clinical studies, no specific adverse events were reported as increased with Lactobacillus plantarum 299v compared to control. In fact, significant reductions in vomiting and flatulence were observed in one study, and no significant differences in postoperative complications or bacterial translocation were found in another. General tolerability was good, with 94% of patients rating long-term treatment as well tolerated in one study, and no adverse effects noted in two study arms. Treatment discontinuation and gastrointestinal intolerance were significantly lower with the probiotic in a study involving enteral nutrition.

Caveats: Limited evidence base (only 4 studies) and most were likely designed for efficacy, not safety, so rare adverse events may not have been detected. Study populations varied (e.g., patients receiving enteral nutrition, postoperative patients), and long-term safety beyond the reported durations (generally weeks to months) has not been established. Findings are specific to the Lp299v strain and formulation used in these trials; other products may differ.

  • Vegan Ideal Bowel Support

    By Jarrow Formulas

    4.6 (2.6K reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $21.37
    		In
    Vitacost
    $19.69
    		In
    Vitamin Shoppe
    $-
    		Out

  • Pro-IBS Support

    By Hyperbiotics

    4 (13 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $32.99
    		In
    Vitacost
    $-
    		Out
    Vitamin Shoppe
    $-
    		Out

  • UltraFlora

    By Metagenics

    4 (1 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $62.43
    		In
    Vitacost
    $-
    		Out
    Vitamin Shoppe
    $-
    		Out
Back to top